TY - JOUR
T1 - SCMR expert consensus statement for cardiovascular magnetic resonance of acquired and non-structural pediatric heart disease
AU - Dorfman, Adam L.
AU - Geva, Tal
AU - Samyn, Margaret M.
AU - Greil, Gerald
AU - Krishnamurthy, Rajesh
AU - Messroghli, Daniel
AU - Festa, Pierluigi
AU - Secinaro, Aurelio
AU - Soriano, Brian
AU - Taylor, Andrew
AU - Taylor, Michael D.
AU - Botnar, René M.
AU - Lai, Wyman W.
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Cardiovascular magnetic resonance (CMR) is widely used for diagnostic imaging in the pediatric population. In addition to structural congenital heart disease (CHD), for which published guidelines are available, CMR is also performed for non-structural pediatric heart disease, for which guidelines are not available. This article provides guidelines for the performance and reporting of CMR in the pediatric population for non-structural (“non-congenital”) heart disease, including cardiomyopathies, myocarditis, Kawasaki disease and systemic vasculitides, cardiac tumors, pericardial disease, pulmonary hypertension, heart transplant, and aortopathies. Given important differences in disease pathophysiology and clinical manifestations as well as unique technical challenges related to body size, heart rate, and sedation needs, these guidelines focus on optimization of the CMR examination in infants and children compared to adults. Disease states are discussed, including the goals of CMR examination, disease-specific protocols, and limitations and pitfalls, as well as newer techniques that remain under development.
AB - Cardiovascular magnetic resonance (CMR) is widely used for diagnostic imaging in the pediatric population. In addition to structural congenital heart disease (CHD), for which published guidelines are available, CMR is also performed for non-structural pediatric heart disease, for which guidelines are not available. This article provides guidelines for the performance and reporting of CMR in the pediatric population for non-structural (“non-congenital”) heart disease, including cardiomyopathies, myocarditis, Kawasaki disease and systemic vasculitides, cardiac tumors, pericardial disease, pulmonary hypertension, heart transplant, and aortopathies. Given important differences in disease pathophysiology and clinical manifestations as well as unique technical challenges related to body size, heart rate, and sedation needs, these guidelines focus on optimization of the CMR examination in infants and children compared to adults. Disease states are discussed, including the goals of CMR examination, disease-specific protocols, and limitations and pitfalls, as well as newer techniques that remain under development.
KW - Cardiovascular magnetic resonance
KW - Children
KW - Guidelines
KW - Pediatric heart disease
UR - http://www.scopus.com/inward/record.url?scp=85134532209&partnerID=8YFLogxK
U2 - 10.1186/s12968-022-00873-1
DO - 10.1186/s12968-022-00873-1
M3 - Review article
C2 - 35864534
AN - SCOPUS:85134532209
SN - 1097-6647
VL - 24
JO - Journal of Cardiovascular Magnetic Resonance
JF - Journal of Cardiovascular Magnetic Resonance
IS - 1
M1 - 44
ER -